Dede Willis
Founder of Orbit Genomics
Dede Willis
Founder of Orbit Genomics
Boulder, Colorado
Overview
Work Experience
CEO and CoFounder
2016 - Current
Orbit Genomics is transforming complex disease diagnosis, treatment and prevention through early warning genomics. Our patent pending OrbiSeq™ platform analyzes novel genomic markers which uniquely reflect not only inherited predisposition to disease, but also risk acquired from lifestyle and environmental exposures. OrbiSeq can be applied to diagnose, treat and help prevent complex diseases including cancer, heart disease and neurological diseases.
Partner
2003
Ventac Partners is a life science company builder with offices in the US, EU and Asia. Ventac Partners has a strong track record of successfully launching new companies, fundraising, deal making and strategic consulting.
Business Mentor
2016 - 2020
Member Board of Directors
2016 - 2019
Panion Animal Health AB ‘s aim is develop and commercialize the canine application of CombiGene AB’s technology for gene therapeutic treatment of drug refractory epilepsy. In addition, Panion plans to inlicense or acquire other, similar assets, i.e. the animal health applications of human health development projects or products. Panion was acquired by CombiGene in 2019.
Chief Operating Officer and CoFounder
2009 - 2014
Boulder Diagnostics Inc. is dedicated to bringing new diagnostic tests to market for diseases that are not reliably diagnosed today. We work with leading academic institutions and innovative companies to identify scientific breakthroughs that can deliver new, reliable diagnostic tests where today’s standard methods fail.
Vice President, Operations
2010 - 2012
Vice President Operations
2004 - 2007
Vice President
1999 - 2002
Managing Director
1999 - 2002
President & CEO
1998 - 1999